Diana Bilton

13.1k total citations · 4 hit papers
199 papers, 7.9k citations indexed

About

Diana Bilton is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Speech and Hearing. According to data from OpenAlex, Diana Bilton has authored 199 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Pulmonary and Respiratory Medicine, 29 papers in Epidemiology and 21 papers in Speech and Hearing. Recurrent topics in Diana Bilton's work include Cystic Fibrosis Research Advances (166 papers), Neonatal Respiratory Health Research (43 papers) and Tracheal and airway disorders (41 papers). Diana Bilton is often cited by papers focused on Cystic Fibrosis Research Advances (166 papers), Neonatal Respiratory Health Research (43 papers) and Tracheal and airway disorders (41 papers). Diana Bilton collaborates with scholars based in United Kingdom, United States and Australia. Diana Bilton's co-authors include Charles Haworth, Adam T. Hill, M. C. Pasteur, J. Foweraker, A.K. Webb, Mary T. Keogan, M Dodd, Bruce C. Marshall, Nicholas J. Simmonds and Richard Coulden and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

Diana Bilton

190 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

British Thoracic Society guideline for non-CFbronchiectasis

2010 727 citations Diana Bilton et al. profile →
An Investigation into Causative Factors in Patients with Bronchiectasis

2000 482 citations J. Foweraker, Richard Coulden et al. American Journal of Respiratory and Critical Care Medicine profile →
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary

2015 360 citations Diana Bilton, Charles Haworth et al. profile →
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

2015 303 citations Diana Bilton, Charles Haworth et al. profile →

Peers

Countries citing papers authored by Diana Bilton

Since Specialization

Citations

This map shows the geographic impact of Diana Bilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Bilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Bilton more than expected).

Fields of papers citing papers by Diana Bilton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Bilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Bilton. The network helps show where Diana Bilton may publish in the future.

Co-authorship network of co-authors of Diana Bilton

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Bilton. A scholar is included among the top collaborators of Diana Bilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Bilton. Diana Bilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review 2022 ·Therapeutic Advances in Respiratory Disease ·(unknown), Mandy Jones, Susan C. Charman, Diana Bilton, Omar S. Usmani, Jane C. Davies, Nicholas J. Simmonds	1
2	Mediation of the total effect of cystic fibrosis‐related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study 2022 ·Diabetic Medicine ·(unknown), Rhian Daniel, Diana Bilton, Nicholas J. Simmonds, Linda Sharples, Ruth H. Keogh	4
3	Trajectories of early growth and subsequent lung function in cystic fibrosis: An observational study using UK and Canadian registry data 2022 ·Journal of Cystic Fibrosis ·Amy MacDougall, Deborah Jarvis, Ruth H. Keogh, Cole Bowerman, Diana Bilton, Gwyneth Davies, S.B. Carr, Sanja Stanojevic	4
4	Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study 2021 ·Journal of Cystic Fibrosis ·Olga Archangelidi, Paul Cullinan, Nicholas J. Simmonds, Emmanouil Mentzakis, D. Peckham, Diana Bilton, S.B. Carr	18
5	Identifying exceptional cystic fibrosis care services: combining statistical process control with focus groups 2019 ·SHILAP Revista de lepidopterología ·Stephanie MacNeill, Livia Pierotti, Mohammed A. Mohammed, Martin J Wildman, Jonathan Boote, Steve Harrison, S.B. Carr, Paul Cullinan, Caroline Elston, Diana Bilton	1
6	Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F 2015 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Catherine J. Reynolds, Amélie Goudet, (unknown), Ruhena Sergeant, Andrew Quigley, Stefan Worgall, Diana Bilton, Robert Wilson, Michael R. Loebinger, Bernard Maillère, Daniel M. Altmann, Rosemary J. Boyton	19
7	ANALYSIS OF LONG-TERM LIPOSOMAL AMIKACIN FOR INHALATION IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC INFECTION FROM PSEUDOMONAS AERUGINOSA 2014 ·Pediatric Pulmonology ·Diana Bilton, T. Pressler, Isabelle Fajac, John P. Clancy, (unknown), Marco Cipolli, (unknown), Amparó Solé, Lieven Dupont, Nicole Mayer-Hamblett, S. Torchio, John P. McGinnis, Gina Eagle, Michael W. Konstan	6
8	Safety, tolerability and efficacy of intravenous aminophylline in adult patients with pulmonary exacerbations of cystic fibrosis 2014 ·European Respiratory Journal ·(unknown), Nicholas J. Simmonds, Diana Bilton	0
9	Inhaled Colistin in Patients with Bronchiectasis and Chronic Pseudomonas aeruginosa Infection 2014 ·American Journal of Respiratory and Critical Care Medicine ·Charles Haworth, J. Foweraker, Peter Wilkinson, (unknown), Diana Bilton	185
10	Inhaled mannitol for non-cystic fibrosis bronchiectasis - results of a 12 month, multi-centre, double-blind, controlled study 2013 ·European Respiratory Journal ·Diana Bilton, Gregory Tino, Alan R. Barker, Daniel C. Chambers, Anthony De Soyza, Lieven Dupont, (unknown), (unknown), Luis Otero Vidal, Tobias Welte, Howard Fox, Jian Wu, Brett Charlton	2
11	PHASE 3 EFFICACY AND SAFETY DATA FROM RANDOMIZED, MULTICENTER STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE) COMPARED WITH TOBI (R) IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC INFECTION DUE TO PSEUDOMONAS AERUGINOSA 2013 ·Pediatric Pulmonology ·Diana Bilton, T. Pressler, (unknown), (unknown), (unknown), Marco Cipolli, (unknown), (unknown), Amparó Solé, Doris Staab, Lieven Dupont, Christopher H. Goss, N. Hamblett, Alexandra L. Quittner, Bonnie W. Ramsey, Renu Gupta, Michael W. Konstan	15
12	A retrospective analysis of the impact of azithromycin maintenance therapy on adults attending a UK cystic fibrosis clinic 2012 ·Journal of Cystic Fibrosis ·(unknown), Kaushik Guha, S. N. Piper, Winston Banya, Diana Bilton, M.E. Hodson	13
13	76 Mannitol inhaler device culture: no evidence of an increased microbiological contamination 2011 ·Journal of Cystic Fibrosis ·Moira L. Aitken, Diana Bilton, (unknown), Herbert Fox, B. Charlton	1
14	78 Combined data from two phase III studies of Bronchitol (inhaled dry powder mannitol) in adult cystic fibrosis (CF) patients 2011 ·Journal of Cystic Fibrosis ·Diana Bilton, Moira L. Aitken, Patrick A. Flume, David E. Geller, Allen Lapey, Jonathan B. Zuckerman, K. De Boeck, G. Bellon, Helge Hebestreit, (unknown), Paul D. Robinson, Patricia Cooper, John Kolbe, John C. Gallagher, Herbert Fox, B. Charlton	2
15	A single centre experience of liver disease in adults with cystic fibrosis 1995–2006 2007 ·Journal of Cystic Fibrosis ·Kathryn Nash, Michael Allison, Damian McKeon, David J. Lomas, (unknown), Diana Bilton, Graeme Alexander	48
16	Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis. 2006 ·Pediatric Pulmonology ·Lorraine Martin, D.G. Downey, Diana Bilton, Mary T. Keogan, (unknown), J.S. Elborn	2
17	Osteoclastogenesis during Infective Exacerbations in Patients with Cystic Fibrosis 2006 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Charles Haworth, E. Gunn, Diana Bilton, Mike Scott, Juliet Compston	44
18	Double Aortic Arch Masquerading as Asthma for Thirty Years 2002 ·Respiration ·Șerban Stoica, Ulf Lockowandt, Richard Coulden, R. Parker Ward, Diana Bilton, John Dunning	16
19	An Investigation into Causative Factors in Patients with Bronchiectasis breakdown → 2000 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), (unknown), (unknown), (unknown), J. Foweraker, Richard Coulden, C.D.R. Flower, Diana Bilton, Mary T. Keogan	482
20	Pathology of common bile duct stenosis in cystic fibrosis. 1990 ·Gut ·Diana Bilton, (unknown), A.K. Webb, W Lawler, R F McMahon, J M Howat	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact